Company Quick10K Filing
BioLargo
10-Q 2021-03-31 Filed 2021-05-17
10-K 2020-12-31 Filed 2021-03-30
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
S-1 2020-04-10 Public Filing
10-Q 2020-03-31 Filed 2020-05-19
10-K 2019-12-31 Filed 2020-03-31
10-Q 2019-09-30 Filed 2019-11-14
S-1 2019-08-29 Public Filing
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
S-1 2018-11-06 Public Filing
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
S-1 2018-01-17 Public Filing
10-K 2017-12-31 Filed 2018-03-16
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-17
10-K 2016-12-31 Filed 2017-03-30
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-15
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-04-01
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-29
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-06
10-Q 2011-09-30 Filed 2011-11-15
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-04-15
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-04-06
8-K 2020-08-04
8-K 2020-07-23
8-K 2020-06-30
8-K 2020-03-31
8-K 2020-03-30
8-K 2020-03-20
8-K 2020-03-03
8-K 2020-02-25
8-K 2020-02-12
8-K 2019-09-23
8-K 2019-07-31
8-K 2019-07-29
8-K 2019-06-18
8-K 2019-06-04
8-K 2019-04-18
8-K 2019-04-01
8-K 2019-03-05
8-K 2019-02-05
8-K 2019-01-23
8-K 2019-01-16
8-K 2019-01-07
8-K 2018-12-17
8-K 2018-10-31
8-K 2018-10-16
8-K 2018-09-26
8-K 2018-09-26
8-K 2018-09-19
8-K 2018-09-12
8-K 2018-08-14
8-K 2018-07-02
8-K 2018-05-31
8-K 2018-05-23
8-K 2018-05-23
8-K 2018-05-07
8-K 2018-03-07
8-K 2018-01-16
8-K 2017-12-31

BioLargo Financials

BLGO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
ALTIMAR ACQUISITION CORP. (ATAC-WT)
AppHarvest, Inc. (APPHW)
24Holdings (TWFH)
AMERICAN CRYOSTEM Corp (CRYO)
BorrowMoney.com, Inc. (BWMY)
CAT9 Group Inc. (CATN)
30DC (TDCH)
CBL & ASSOCIATES PROPERTIES INC (CBLEQ)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash19012831151542815191685392363318152154227975601,7631,0228891,7321,9101,1764341,2529909226515346555127062,136
Accounts Receivable101018127128151443567838412747836862781149410290112257210232306
Inventory696263555254524136303425632621151337322426342537395457264626263819
PP&E4311155559545055109117122125126110108106
Assets3012464486385432692011741381674854262972613832647681,9101,1901,0231,9682,1131,4986431,7411,4951,4551,1681,0893,1853,3953,5835,104
Accounts Payable9459282257159277172274149242302370328297
Long-Term Debt5145141001001001003255050502506131,0432,1673,2463,5143,7965,7285,8615,7615,8066,3616,7887,1681,6551,4432,6573,3143,0735,924
Liabilities2,6001,7642,1941,5761,5945586827485017325094816236538357495117699731,4512,1282,8833,1204,1194,1434,9056,0701,8122,0704,3085,1885,5026,114
Stockholders' Equity-2,299-1,518-1,746-938-1,051-290-481-574-363-565-24-55-326-392-414-4852571,141218-1,325-2,114-3,754-3,090-4,104-5,203-1,137-1,356-1,496-2,082-2,127-1,120
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue12114311410101412418159211665274065514391626646100172186263327277364426534
Cost of Revenue13818877613863983768202861647372373123104163201122192228266
Gross Profit10851364381111097129282032-14278231152923274995100126155172198268
R&D9511644541151147268139164129187163138167162217351330349352391324426488522426443426367332
SG&A5817127001,5368281,5475974755365346079496525855618591,4556769319249898711,0551,1621,1181,0941,1701,3171,3661,3921,3021,803
Tax100002000040315000060300
Net Income-712-910-921-1,776-916-1,721-645-539-698-646-1,019-1,058-826-745-780-1,294-1,821-1,259-1,644-1,668-2,484-2,278-2,060-2,094-2,246-2,401-2,430-3,600-2,380-2,749-1,987-3,887
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-382-379-737-546-371-465-362-164-221-557-452-408-302-275-539-527-543-987-1,105-922-1,176-872-1,208-996-1,057-998-869-982-1,330
Cash Investing0000-50-7-20-19-8-160-14-13
Cash Financing321561941459944053391502608284072413053474089901,7872552,0101,1264531359719388019037301,1942,766